Brexpiprazole

Details

Files

Generic Name:

Brexpiprazole

Project Status:

Complete

Therapeutic Area:

schizophrenia

Manufacturer:

Otsuka-Lundbeck

Call for patient/clinician input open:

January 4, 2017

Brand Name:

Rexulti

Project Line:

Reimbursement Review

Project Number:

SR0514-000

Call for patient/clinician input closed:

February 23, 2017

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Schizophrenia

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

November 22, 2017

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : January 4, 2017